Next report date
Report period
Q1 2024
EPS estimate
−0.23USD
Revenue estimate
—
−15.43 MUSD
13.85 M
Om Immix Biopharma, Inc.
Sektor
Bransch
VD
Ilya Rachman
Webbplats
Huvudkvarter
Los Angeles
Employees (FY)
17
Grundat
2012
FIGI
BBG00HLCWH09
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
